Metabolic and cardiovascular assessment in moderate obesity: Effect of weight loss

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 9, 1997, Pages 2937-2943

  Muscelli, Elza ^a   Camastra, Stefania ^a   Catalano, Carlo ^a   Galvan, Alfredo Quiñones ^a   Ciociaro, Demetrio ^a   Baldi, Simona ^a   Ferrannini, Ele ^a,b  

^a UNIVERSITY OF PISA   (Italy)

^b INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; ENERGY EXPENDITURE; FEMALE; HEART OUTPUT; HEART STROKE VOLUME; HEMODYNAMICS; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; MALE; METABOLIC DISORDER; OBESITY; PRIORITY JOURNAL; WEIGHT REDUCTION;

EID: 0030883933     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.82.9.4228     Document Type: Article

References (46)

1. Olefsky JM, Kolterman OG, Scarlett JA. 1982 Insulin action and resistance in obesity and non insulin-dependent type I diabetes mellitus. Am J Physiol. 243:E15-E30.
2. DeFronzo RA. 1982 Insulin secretion, insulin resistance, and obesity. Int J Obesity. 6:73-82.
3. Mujais SK, Tarazi RC, Dustan HP, Fouad FM, Bravo EL. 1982 Hypertension in obese patients: hemodynamic and volume studies. Hypertension. 4:84-92.
4. Messerli FH, Sundgaard-Rise K, Dreslinki G, Dunn FG, Frohlich E. 1983 Disparate cardiovascular effects of obesity and arterial hypertension. Am J Med. 74:808-812.
5. Landsberg L. 1986 Diet, obesity and hypertension: an hypothesis involving insulin, the sympathetic nervous system, and adoptive thermogenesis. Q J Med. 236:1081-1090.
6. Marcus R, Krause L, Weder AB, Domingues-Meja A, Schork NJ, Julius S. 1994 Sex-specific determinants of increased left ventricular mass in the Tecumseh Blood Pressure Study. Circulation. 90:928-936.
7. Lissner L, Odell PM, D'Agostino RB, et al. 1991 Variability of body weight and health outcomes in the Framingham population. N Engl J Med. 315:1839-1844.
8. Manson JE, Colditz GA, Stampfer MJ, et al. 1990 A prospective study of obesity and risk of coronary heart disease in women. N Engl J Med. 322:882-889.
9. Reaven GM. 1988 Role of insulin resistance in human disease. Diabetes. 37:1595-1607.
10. Pyorala K. 1991 Hyperinsulinemia as predictor of cardiovascular disease: epidemiological evidence. Diabetes Metab. 17:87-92.
11. Després J, Lamarche B, Mauriege P, et al. 1996 Hyperinsulinemia as an independente risk factor for ischemic heart disease. N Engl J Med. 334:952-957.
12. Su HY, Sheu WH, Chin HM, Jeng CY, Chen YD, Reaven GM. 1995 Effect of weight loss on blood pressure and insulin resistance in normotensive and hypertensive obese individuals. Am J Hypertens. 8:1067-1071.
13. Niskanen L, Uusitupa M, Sarlund H, Siitonen O, Paljarvi L, Laakso M. 1996 The effects of weight loss on insulin sensitivity, skeletal muscle composition and capillary density in obese non-diabetic subjects. Int J Obes. 20:154-160.
14. Burstein R, Epstein Y, Charuzi I, Suessholz A, Karnieli E, Shapiro Y. 1995 Glucose utilization in morbidly obese subjects before and after weight loss by gastric bypass operation. Int J Obes. 19:558-561.
15. Webber J, Donaldson M, Allison SP, Fukugawa NK, MacDonald IA. 1994 The effects of weight loss in obese subjects on the thermogenic, metabolic and haemodynamic responses to the glucose clamp. Int J Obes. 18:725-730.
16. Friedman JE, Dohm GL, Leggett-Frazier N, et al. 1992 Restoration of insulin responsiveness in skeletal muscle of morbidly obese patients after weight loss. J Clin Invest. 89:701-705.
17. Tuck ML, Sowers J, Dornfeld L, Kledzik G, Maxwell M. 1981 The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients. N Engl J Med. 304:930-933.
18. Reisin E, Frolich ED, Messerli FH, et al. 1983 Cardiovascular changes after weight reduction in obesity hypertension. Ann Intern Med. 000:315-319.
19. National Diabetes Data Group. 1979 Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance diabetes. 28:1039-1057.
20. Joint National Committee. 1993 The fifth report of the Joint National Committee on detection, evaluation, and treatment of high blood pressure (JNC V). Arch Intern Med. 153:154-183.
21. Fulcher GR, Farrer M, Walker M, Rodham D, Clayton B, Alberti KGM. 1991 A comparison of measurements of lean body mass derived by bioelectrical impedance, skinfold tickness and total body potassium. A study in obese and non-obese normal subjects. Scand J Lab Invest. 51:245-253.
22. DeFronzo RA, Tobin JD, Andres R. 1979 Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223.
23. McGuire EAH, Heldermann JH, Tobin JD, Andres R, Berman M. 1976 Effects of arterial versus venous sampling on analysis of glucose kinectics in man. J Appl Physiol. 41:1312-1318.
24. Otterstad JE, Simonse E, Myhre E. 1984 Determination of cardiac output by echocardiography. Br Heart J. 51:54-60.
25. Butler PC, Caumo A, Zerman A, O'Brien PC, Cobelli C, Rizza RA. 1993 Methods for the assesment of the rate of onset and offset of insulin action during nonsteady state in humans. Am J Physiol. 264:E548-E560.
26. Ferrannini E. 1988 The theoretical bases of indirect calorimetry: a review. Metabolism. 37:287-301.
27. DeFronzo RA, Ferrannini E, Hendler R, Felig P, and Wahren J. 1983 Regulation of splanchnic and peripheral glucose uptake by insulin and hyperglycemia in man. Diabetes. 32:35-45.
28. Cobelli C, Mari A, and Ferrannini E. 1987 The non-steady state problem: error analysis of Steele's model and developments for glucose kinetics. Am J Physiol. 252:E679-E687.
29. Elahi D, Nagulesparan M, Herchcopf RJ, et al. 1982 Feedback inhibition of insulin secretion by insulin: relation to the hyperinsulinemia of obesity. N Engl J Med. 306:1196-1199.
30. Ferrannini E, Cobelli C. 1987 The kinectics of insulin in man. I. General aspects. Diabetes Metab Rev. 3:335-363.
31. Cobelli C, Mari A, and Ferrannini E. 1986 On the linearity of insulin kinetics. Am J Physiol. 251:E247.
32. Kahn S, Prigeon R, Macculloch D, et al. 1983 Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes. 42:1663-1672.
33. Jéquier E. 1984 Energy expenditure in obesity. Clin Endocrinol Metab. 13:563-580.
34. Bonadonna RC, Groop L, Kraemer N, Ferrannini E, Del Prato S, DeFronzo RA. 1990 Obesity and insulin resistance in humans: a dose-response study. Metabolism. 39:452-459.
35. Ferrannini E, Cobelli C. 1987 The kinectics of insulin in man. II. Role of the liver. Diabetes Metab Rev. 3:364-375.
36. Jéquier E. 1990 Energy metabolism in obese patients before and after weight loss, and in patients who have relapsed. Int J Obes. 14(Suppl 1):59-67.
37. Holte J, Bergh T, Berne C, Wide L, Lithell H. 1995 Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab. 80:2586-2593.
38. Jimenez J, Zuniga-Guajardo S, Zinman B, Angel A. 1987 Effects of weight loss in massive obesity on insulin and C-peptide dynamics: sequential changes in insulin production, clearance, and sensitivity. J Clin Endocrinol Metab. 64:661-668.
39. Jameson JL, DeGroot LJ. 1995 Mechanisms of thyroid hormone action. In: Besser M, Burger HG, Jameson JL, et al., eds Endocrinology, 3rd ed. Philadelphia: Saunders; 583-601.
40. Sowers JR, Nyby M, Stern N, et al. 1982 Blood pressure and hormone changes associated with weight reduction in the obese. Hypertension. 4:686-691.
41. O'Dea K, Esler M, Leonard P, Stockigt JR, Nestel P. 1995 Noradrenaline turnover during under- and over-eating in normal weight subjects. Metabolism. 44:611-616.
42. Reisin E, Abel R, Modan M, et al. 1978 Effect of weight loss without salt restriction on the reduction of blood pressure in overweight hypertensive patients. N Engl J Med. 298:1-6.
43. Ferrannini E. 1992 The haemodynamics of obesity: a theoretical analysis. J Hypertens. 10:1417-1423.
44. Barret-Connor E, Khaw K-T. 1985 Is hypertension more benign when associated with obesity? Circulation. 75:53-60.
45. Bloom E, Reed D, Yano K, MacLean C. 1986 Does obesity protect hypertensives against cardiovascular disease? JAMA. 256:2972-2975.
46. Stamler R, Ford CE, Stamler J. 1991 Why do lean have higher mortality rates than other hypertensives? Findings of the Hypertension Detection and Follow-up Program. Hypertension. 17:553-564.